Two Sigma Investments’s GSK GSK Stock Holding History

Two Sigma Investments’s Portfolio GSK Stock Details GSK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-36,300	Closed	-$1.97M	–	4720
2025 Q4	$1.78M	Sell	36,300 -53,200	-59%	-$2.48M	﹤0.01%	2526
2025 Q3	$3.86M	Hold	89,500	–	–	0.01%	1657
2025 Q2	$3.44M	Hold	89,500	–	–	0.01%	1479
2025 Q1	$3.47M	Sell	89,500 -485,254	-84%	-$17.8M	0.01%	1346
2024 Q4	$19.4M	Buy	574,754 +492,934	+602%	+$17.7M	0.04%	486
2024 Q3	$3.34M	Buy	+81,820	New	+$3.35M	0.01%	1321
2024 Q1	–	Sell	-290,575	Closed	-$10.8M	–	3161
2023 Q4	$10.8M	Buy	+290,575	New	+$10.4M	0.02%	651
2023 Q1	–	Sell	-557,990	Closed	-$19.6M	–	3048
2022 Q4	$19.6M	Sell	557,990 -6,579,584	-92%	-$219M	0.06%	362
2022 Q3	$210M	Buy	7,137,574 +5,872,980	+464%	+$223M	0.71%	17
2022 Q2	$68.8M	Buy	1,264,594 +1,258,867	+21,981%	+$69.5M	0.23%	114
2022 Q1	$312K	Sell	5,727 -1,532,409	-100%	-$83.2M	﹤0.01%	2200
2021 Q4	$84.8M	Sell	1,538,136 -1,227,678	-44%	-$63.9M	0.18%	136
2021 Q3	$132M	Buy	2,765,814 +2,707,527	+4,645%	+$136M	0.3%	80
2021 Q2	$2.9M	Sell	58,287 -394,400	-87%	-$19M	0.01%	1575
2021 Q1	$20.2M	Buy	+452,687	New	+$20.5M	0.05%	429
2020 Q4	–	Sell	-136,259	Closed	-$6.41M	–	3487
2020 Q3	$6.41M	Sell	136,259 -1,102,083	-89%	-$55.2M	0.02%	694
2020 Q2	$63.1M	Buy	1,238,342 +247,688	+25%	+$12.7M	0.31%	62
2020 Q1	$46.9M	Buy	990,654 +448,849	+83%	+$23.9M	0.38%	38
2019 Q4	$31.8M	Sell	541,805 -1,039,045	-66%	-$57.8M	0.1%	253
2019 Q3	$84.3M	Buy	1,580,850 +484,939	+44%	+$24.9M	0.28%	72
2019 Q2	$54.8M	Buy	1,095,911 +173	+0%	+$8.68K	0.18%	131
2019 Q1	$57.2M	Buy	1,095,738 +762,091	+228%	+$38.1M	0.19%	138
2018 Q4	$15.9M	Buy	+333,647	New	+$16.4M	0.06%	386
2018 Q3	–	Sell	-179,735	Closed	-$9.06M	–	3339
2018 Q2	$9.06M	Sell	179,735 -518,255	-74%	-$26.1M	0.03%	711
2018 Q1	$34.1M	Sell	697,990 -1,212,544	-63%	-$56.5M	0.11%	227
2017 Q4	$84.7M	Buy	1,910,534 +365,820	+24%	+$16.9M	0.28%	75
2017 Q3	$78.4M	Sell	1,544,714 -175,897	-10%	-$8.92M	0.28%	91
2017 Q2	$92.7M	Buy	1,720,611 +71,953	+4%	+$3.84M	0.34%	60
2017 Q1	$86.9M	Sell	1,648,658 -719,769	-30%	-$36.5M	0.29%	63
2016 Q4	$114M	Buy	2,368,427 +846,005	+56%	+$41.8M	0.44%	34
2016 Q3	$82.1M	Sell	1,522,422 -41,734	-3%	-$2.29M	0.3%	72
2016 Q2	$84.7M	Buy	1,564,156 +145,742	+10%	+$7.68M	0.36%	56
2016 Q1	$71.9M	Buy	1,418,414 +617,939	+77%	+$30.8M	0.34%	62
2015 Q4	$40.4M	Sell	800,475 -298,560	-27%	-$15.2M	0.19%	132
2015 Q3	$52.8M	Sell	1,099,035 -596,363	-35%	-$31M	0.27%	105
2015 Q2	$88.3M	Buy	1,695,398 +86,366	+5%	+$4.86M	0.41%	44
2015 Q1	$92.8M	Buy	1,609,032 +134,851	+9%	+$7.73M	0.43%	35
2014 Q4	$78.8M	Sell	1,474,181 -410,670	-22%	-$23M	0.44%	35
2014 Q3	$108M	Buy	1,884,851 +817,268	+77%	+$50.1M	0.48%	37
2014 Q2	$71.4M	Buy	1,067,583 +35,965	+3%	+$2.43M	0.32%	67
2014 Q1	$68.9M	Buy	1,031,618 +180,689	+21%	+$12.2M	0.37%	54
2013 Q4	$56.8M	Buy	850,929 +21,485	+3%	+$1.39M	0.31%	70
2013 Q3	$52M	Sell	829,444 -93,074	-10%	-$5.99M	0.33%	73
2013 Q2	$57.6M	Buy	+922,518	New	+$58.6M	0.4%	46

Other funds holding GSK

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

JEST

JTC Employer Solutions Trustee St Helier, Jersey $1.2B AUM 37.55% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Two Sigma Investments's GSK Position: Q1 2026 in Review

Two Sigma Investments sold out of GSK (GSK) in Q1 2026, closing a stake of 36,300 shares — an estimated $1.97M sold.

Two Sigma Investments first reported a position in GSK in Q2 2013 and held it in 44 quarters. The position peaked at $210M in Q3 2022. 1,031 funds tracked by Wall St. Rank hold GSK as of Q1 2026.

Two Sigma Investments reported no remaining GSK position as of Q1 2026 after selling out during the quarter.
Two Sigma Investments sold 36,300 GSK shares in Q1 2026, an estimated $1.97M.
Two Sigma Investments first reported a position in GSK in Q2 2013 and held it in 44 quarters.
Two Sigma Investments's GSK position peaked at $210M in Q3 2022.
1,031 funds tracked by Wall St. Rank held GSK as of Q1 2026.

Based on Two Sigma Investments's 13F filing for Q1 2026, filed 15 May 2026.